Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation

NCT01040637 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

NCT01901341 ·Status: TERMINATED ·Phase: PHASE3

Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation

NCT01117051 ·Status: TERMINATED ·Phase: PHASE3

Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients

NCT00799201 ·Status: TERMINATED ·Phase: PHASE4

A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation

NCT00511771 ·Status: NO_LONGER_AVAILABLE

A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation

NCT00563758 ·Status: TERMINATED ·Phase: NA

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.

NCT03638440 ·Status: COMPLETED

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation

NCT01459926 ·Status: COMPLETED ·Phase: PHASE2

Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients

NCT02946580 ·Status: TERMINATED ·Phase: PHASE4

A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

NCT01401985 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

NCT01993940 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications

NCT01096290 ·Status: TERMINATED ·Phase: PHASE4

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

NCT03060512 ·Status: COMPLETED ·Phase: PHASE4

CMTS4520 for Chronic Constipation in Adults

NCT06832137 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain

NCT00366431 ·Status: COMPLETED ·Phase: PHASE2

A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

NCT00401362 ·Status: COMPLETED ·Phase: PHASE3

Study of Methylnaltrexone (MNTX) for the Relief of Constipation

NCT00402038 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia

NCT00277550 ·Status: WITHDRAWN ·Phase: PHASE4

Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method

NCT00563615 ·Status: UNKNOWN ·Phase: NA

Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.

NCT00141089 ·Status: COMPLETED ·Phase: PHASE3

Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients

NCT01189409 ·Status: TERMINATED ·Phase: PHASE4

Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With Naloxegol

NCT04173858 ·Status: COMPLETED

A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)

NCT00600119 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation

NCT00149877 ·Status: COMPLETED ·Phase: PHASE4

Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications

NCT05133076 ·Status: COMPLETED ·Phase: PHASE2